```markdown
©Steinkopff Verlag 1999

# Basic Research in Cardiology, Vol. 94, No. 1 (1999)

## Table 3: Myocardial blood flow in subepicardial and subendocardial septum

| Patient | Symptoms | bas | bas | dip | dip | post | post | post | post | Pre | Pre | Post | Post | CFR | CFR | CFR | CFR |
|---------|----------|-----|-----|-----|-----|------|------|------|------|-----|-----|------|------|-----|-----|-----|-----|
|         |          | endo | epi | endo | epi | bas | epi | dip | epi | bas | bas | dip | dip | endo | epi | endo | epi |
|         |          |      |     |      |     |     |     |     |     |     |     |     |     |     |      |     |     |
| 1       | A         | 1.46 | 1.41 | 1.17 | 1.75 | 0.94 | 0.74 | 0.93 | 0.89 | 1.03 | 1.26 | 0.67 | 1.07 | 0.80 | 1.24 | 0.99 | 1.19 |
| 2       | A         | 0.98 | 1.02 | 0.86 | 1.08 | 0.78 | 0.78 | 0.93 | 0.93 | 0.96 | 1.00 | 0.79 | 0.91 | 1.02 | 1.06 | 1.16 | 1.20 |
| 3       | B         | 0.76 | 0.59 | 0.78 | 0.78 | 0.78 | 0.78 | 0.92 | 0.92 | 1.28 | 1.28 | 1.26 | 1.26 | 1.00 | 1.00 | 1.00 | 1.00 |
| 4       | –         | 0.80 | 0.81 | 0.79 | 0.89 | –     | –     | –     | –     | –     | –     | –     | 0.77 | –     | –     | 0.98 | 1.09 |
| 5       | A         | 1.36 | 0.82 | 1.32 | 1.56 | 0.79 | 0.80 | 1.42 | 1.42 | 1.16 | 1.16 | 0.67 | 0.66 | 0.97 | 1.91 | 1.80 | 2.70 |
| 6       | A         | 0.93 | 0.87 | 1.24 | 1.56 | 1.87 | 1.40 | 1.62 | 1.62 | 1.18 | 1.18 | 1.34 | 1.34 | 1.38 | 1.79 | 1.86 | 0.84 |
| 7       | A         | 1.33 | 1.25 | 1.00 | 1.59 | 1.56 | 0.24 | 0.94 | 0.94 | 1.07 | 1.07 | 0.64 | 0.64 | 0.75 | 1.27 | 1.60 | 0.99 |
| 8       | B         | 0.56 | 0.47 | 1.22 | 1.11 | 0.51 | 1.04 | 1.04 | 1.04 | 1.03 | 1.03 | 1.09 | 1.09 | 2.16 | 2.38 | 1.86 | 2.01 |
| 9       | B         | 0.90 | 0.90 | 0.90 | 1.47 | 0.75 | 0.76 | 1.41 | 1.41 | 1.42 | 1.42 | 0.98 | 0.98 | 1.00 | 1.63 | 1.89 | 1.87 |
| 10      | B         | 0.67 | 0.63 | 1.57 | 1.92 | 1.14 | 1.01 | 1.27 | 1.27 | 1.18 | 1.18 | 1.06 | 1.06 | 2.33 | 3.02 | 1.11 | 1.16 |
| 11      | A         | 1.22 | 1.18 | 1.46 | 1.25 | 1.21 | 1.42 | 1.74 | 1.74 | 1.62 | 1.62 | 1.04 | 1.04 | 1.19 | 1.06 | 1.43 | 1.14 |
| 12      | B         | 1.12 | 0.94 | 1.21 | 1.15 | 0.88 | 0.70 | 1.78 | 1.78 | 1.20 | 1.20 | 1.05 | 1.05 | 1.07 | 1.22 | 1.03 | 1.71 |
| 13      | A         | 0.86 | 0.74 | 1.08 | 0.95 | 1.05 | 0.93 | 1.08 | 1.08 | 1.17 | 1.17 | 1.15 | 1.15 | 1.30 | 2.26 | 1.89 | 1.89 |
| 14      | A         | 1.35 | 1.14 | 1.93 | 1.59 | 1.00 | 1.25 | 1.05 | 1.05 | 1.19 | 1.19 | 1.39 | 1.39 | 1.17 | 1.22 | 1.78 | 1.05 |
| 15      | B         | 0.69 | 0.69 | 0.95 | 1.19 | 0.85 | 0.55 | 0.83 | 0.83 | 1.05 | 1.05 | 1.56 | 1.56 | 0.80 | 1.71 | 0.97 | 1.92 |

| Mean     | 1.00 | 0.90 | 1.16 | 1.30 | 1.05 | 0.89 | 1.20 | 1.20 | 1.13 | 1.18 | 0.93 | 1.06 | 1.24 | 1.54 | 1.24 | 1.43 |
| SD       | 0.29 | 0.26 | 0.32 | 0.34 | 0.38 | 0.29 | 0.36 | 0.36 | 0.35 | 0.18 | 0.21 | 0.24 | 0.24 | 0.46 | 0.56 | 0.47 | 0.54 |

Key: Symptoms = change in symptomatic status after verapamil; A = improved (n = 8); B = worsened or no change (n = 6); dip = dipyridamole; bas = baseline; endo = subendocardial; epi = subepicardial; Endo/Endo = subendocardial/subepicardial flow ratio; pre/post = pre and post verapamil therapy respectively; CFR = coronary flow reserve (dipyridamole/baseline myocardial blood flow). All values of myocardial blood flow are in ml/min/g

Fig. 3: Values of myocardial blood flow (MBF) for subendocardial (endo) and subepicardial (epi) septal regions before and after treatment in patients that improved symptomatically following drug therapy (group A) and in those that reported no change or a worsening of symptoms (group B). All values represent mean ± 1 standard deviation.

* p = 0.006; ** p = 0.005; *** p = 0.03; **** p = 0.02
```